MATT ETEM KALAYCIO
Medical Practice in Cleveland, OH

License number
Pennsylvania MD042645L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address 2
Cleveland, OH 44195
Pennsylvania

Professional information

Matt E Kalaycio Photo 1

Dr. Matt E Kalaycio, Cleveland OH - MD (Doctor of Medicine)

Specialties:
Hematology, Medical Oncology, Oncology
Address:
Cleveland Clinic
9500 Euclid Ave, Cleveland 44195
(216) 444-2273 (Phone)
Certifications:
Hematology, 2004, Internal Medicine, 2002, Medical Oncology, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Cleveland Clinic
9500 Euclid Ave, Cleveland 44195
Cleveland Clinic
9500 Euclid Ave, Cleveland 44195
Fairview Hospital
18101 Lorain Ave, Cleveland 44111
Fox Chase Cancer Center
333 Cottman Ave, Philadelphia 19111
Hillcrest Hospital
6780 Mayfield Rd, Mayfield Heights 44124
Education:
Medical School
West Virginia University School Of Medicine
Graduated: 1988
Mercy Hosptial Of Pittsburgh
Graduated: 1989
Mercy Hospital
Graduated: 1991
Cleveland Clin Found
Graduated: 1994


Matt Kalaycio Photo 2

Matt Kalaycio, Cleveland OH

Work:
Cleveland Clinic
9500 Euclid Ave, Cleveland, OH 44185


Matt E Kalaycio Photo 3

Matt E Kalaycio, Cleveland OH

Specialties:
Internist
Address:
9500 Euclid Ave, Cleveland, OH 44195
Education:
West Virginia University, School of Medicine - Doctor of Medicine
Cleveland Clinic Hospital - Fellowship - Hematology and Oncology (Internal Medicine)
UPMC Mercy - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)


Matt Kalaycio Photo 4

Method Of Treating C-Kit Positive Relapsed Acute Myeloid Leukemia

US Patent:
2011028, Nov 17, 2011
Filed:
Dec 3, 2009
Appl. No.:
13/132015
Inventors:
Anjali Advani - Cleveland OH, US
Matt Kalaycio - Cleveland OH, US
Assignee:
CLEVELAND CLINIC - Cleveland OH
International Classification:
A61K 31/704, A61P 35/02
US Classification:
514 34
Abstract:
The present invention relates to a method of treating c-kit positive relapsed acute myeloid leukemia (AML) in a human patient population using a combination comprising a c-kit inhibitor, daunorubicin and cytarabine.